We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH’s Shuren: Look for Framework, Report on Trial Improvement Strategies
CDRH’s Shuren: Look for Framework, Report on Trial Improvement Strategies
The FDA plans to release a document later this year that will explain how devicemakers can use the agency’s benefit-risk framework for device approval when designing different types of clinical trials, CDRH Director Jeffrey Shuren said Wednesday.